Editas Medicine Ownership | Who Owns Editas Medicine?
Editas Medicine Ownership Summary
Editas Medicine is owned by 24.17% institutional investors, 0.61% insiders, and 75.23% retail investors. Blackrock is the largest institutional shareholder, holding 9.50% of EDIT shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.12% of its assets in Editas Medicine shares.
EDIT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Editas Medicine | 24.17% | 0.61% | 75.23% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 7.78M | 9.50% | $36.34M |
| Blackrock funding, inc. /de | 7.31M | 8.86% | $9.28M |
| Vanguard group | 6.82M | 8.27% | $8.67M |
| Millennium management | 2.75M | 3.33% | $3.49M |
| Dimensional fund advisors lp | 2.16M | 2.62% | $2.74M |
| State street | 1.87M | 2.27% | $2.38M |
| Geode capital management | 1.81M | 2.19% | $2.30M |
| Goldman sachs group | 1.79M | 2.17% | $2.27M |
| Two sigma advisers, lp | 1.66M | 2.01% | $2.10M |
| Two sigma investments, lp | 1.65M | 2.00% | $2.09M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Monaco asset management sam | 1.07M | 0.20% | $1.36M |
| Green alpha advisors | 111.63K | 0.11% | $141.77K |
| Aristides capital | 131.90K | 0.03% | $167.51K |
| Tang capital management | 400.00K | 0.03% | $508.00K |
| Hennion & walsh asset management | 267.76K | 0.02% | $340.05K |
| Kennedy capital management | 528.84K | 0.01% | $671.62K |
| Dlk investment management | 25.72K | 0.01% | $32.66K |
| Point72 asia (singapore) pte. | 36.34K | 0.01% | $46.16K |
| Xtx topco | 105.06K | 0.01% | $133.42K |
| Scientech research | 24.35K | 0.01% | $30.93K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Renaissance | 1.45M | 0.00% | 1.45M |
| Balyasny asset management | 1.30M | 0.00% | 1.13M |
| Monaco asset management sam | 1.07M | 0.20% | 1.07M |
| Ubs group | 1.12M | 0.00% | 704.47K |
| Aqr capital management | 1.07M | 0.00% | 693.96K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -4.90M |
| Avidity partners management lp | - | - | -1.47M |
| Pictet asset management sa | - | - | -1.16M |
| Qube research | - | - | -1.05M |
| Morgan stanley | 918.23K | 0.00% | -865.50K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Monaco asset management sam | 1.07M | 0.20% | 1.07M | $1.36M |
| Tang capital management | 400.00K | 0.03% | 400.00K | $508.00K |
| Susquehanna fundamental investments | 272.43K | 0.00% | 272.43K | $345.99K |
| Raymond james financial | 238.97K | 0.00% | 238.97K | $303.49K |
| Acadian asset management | 193.59K | 0.00% | 193.59K | $244.00K |
Sold Out
| Holder | Change |
|---|---|
| Gps wealth strategies group | -2.00 |
| Pacific capital wealth advisors | -5.00 |
| Sittner & nelson | -6.00 |
| Baldwin brothers llc/ma | -8.00 |
| Abich financial wealth management | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 94 | -60.17% | 19,933,396 | -63.85% | 24 | 0.54% | 38 | -62.00% | 22 | -65.63% |
| Sep 30, 2024 | 234 | -2.50% | 55,137,509 | -2.17% | 66 | 1.43% | 100 | -10.71% | 64 | -12.33% |
| Jun 30, 2024 | 238 | 2.15% | 56,360,093 | -17.01% | 68 | 0.86% | 111 | - | 71 | 16.39% |
| Mar 31, 2024 | 233 | 0.87% | 67,911,289 | 16.06% | 89 | 1.74% | 111 | 16.84% | 61 | -12.86% |
| Dec 31, 2023 | 231 | 1.32% | 58,514,008 | -4.86% | 71 | 0.97% | 95 | -5.94% | 70 | 11.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 2.59M | 3.12% | - |
| Vanguard Total Stock Mkt Idx Inv | 2.59M | 3.12% | - |
| iShares Russell 2000 ETF | 2.19M | 2.64% | -19.03K |
| Vanguard Strategic Equity Inv | 1.37M | 1.66% | 183.99K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.37M | 1.65% | - |
| Pictet Biopharmaceutical Mother | 1.15M | 1.38% | 42.67K |
| Vanguard Small Cap Index | 1.04M | 1.26% | 2.50K |
| UBS (Lux) Digital Health Equity SB USD | 800.00K | 0.96% | -370.00K |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 800.00K | 0.96% | -370.00K |
| iShares Russell 2000 Value ETF | 778.74K | 0.94% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2025 | Lucera Erick | EVP, CHIEF FINANCIAL OFFICER | Sell | $7.03K |
| Mar 04, 2025 | O'Neill Gilmore Neil | CEO | Sell | $28.45K |
| Mar 04, 2025 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $4.95K |
| Dec 03, 2024 | O'Neill Gilmore Neil | CEO | Sell | $3.36K |
| Dec 03, 2024 | Mei Baisong | EVP, CHIEF MEDICAL OFFICER | Sell | $1.12K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 4 |
| 2024 Q2 | 1 | 3 |
EDIT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools